Axitinib for treating advanced renal cell carcinoma after failure of prior systemic treatment

Technology appraisal guidance
Reference number: TA333
Published: 25 February 2015

Renal cell carcinoma (advanced) - axitinib: comments on the ACD received from the public through the NICE website

Renal cell carcinoma (advanced) - axitinib: comments on the ACD received from the public through the NICE website

Renal cell carcinoma (advanced) - axitinib: comments on the ACD received from the public through the NICE website
28 March 2013
(37.7 Kb 10 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 26 March 2013